(19)
(11) EP 4 065 108 A1

(12)

(43) Date of publication:
05.10.2022 Bulletin 2022/40

(21) Application number: 20893667.4

(22) Date of filing: 25.11.2020
(51) International Patent Classification (IPC): 
A61K 31/4188(2006.01)
A61K 47/02(2006.01)
A61K 31/495(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/495; A61K 9/0053; A61K 47/14; A61K 47/22; A61P 35/00; A61K 31/444; A61K 31/09
 
C-Sets:
  1. A61K 31/495, A61K 2300/00;
  2. A61K 31/444, A61K 2300/00;
  3. A61K 31/09, A61K 2300/00;

(86) International application number:
PCT/US2020/062288
(87) International publication number:
WO 2021/108601 (03.06.2021 Gazette 2021/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.11.2019 US 201962939823 P
21.09.2020 US 202063081098 P

(71) Applicants:
  • The Johns Hopkins University
    Baltimore, Maryland 21218 (US)
  • Academia Sinica
    Taipei 11529 (TW)
  • National Chiao Tung University
    Hsinchu City 30010 (TW)

(72) Inventors:
  • HUANG, Ru Chih C.
    Baltimore, Maryland 21218 (US)
  • CHUN, Jong Ho
    Baltimore, Maryland 21218 (US)
  • LIN, Yu-Ling
    Taipei, 11529 (TW)
  • LIANG, Yu-Chuan
    Taipei, 11529 (TW)
  • LIAO, Kunag-Wen
    Hsinchu City, 30010 (TW)
  • JACKSON, Tiffany
    Baltimore, Maryland 21218 (US)
  • MOLD, David
    Baltimore, Maryland 21218 (US)
  • LAI, Chien-Hsien
    Baltimore, MD 21218 (US)

(74) Representative: Murgitroyd & Company 
Murgitroyd House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) FORMULATIONS OF TERAMEPROCOL AND TEMOZOLOMIDE AND THEIR USE IN STIMULATION OF HUMORAL IMMUNITY IN TUMORS